Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.
Identifieur interne : 001182 ( PubMed/Curation ); précédent : 001181; suivant : 001183Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.
Auteurs : Balasubramaniyan Malathi [Inde] ; Santhanam Mona [Inde] ; Devasena Thiyagarajan [Inde] ; Perumal Kaliraj [Inde]Source :
- International journal of biological macromolecules [ 1879-0003 ] ; 2015.
Descripteurs français
- KwdFr :
- Activation des lymphocytes (immunologie), Agranulocytes (immunologie), Animaux, Antigènes d'helminthe (immunologie), Brugia malayi (immunologie), Chitosane (), Chitosane (immunologie), Filariose lymphatique (), Humains, Nanosphères (), Nanosphères (ultrastructure), Spectroscopie infrarouge à transformée de Fourier, Thiorédoxines (administration et posologie), Thiorédoxines (immunologie), Thiorédoxines (isolement et purification), Vaccins (), Vaccins (immunologie).
- MESH :
- administration et posologie : Thiorédoxines.
- immunologie : Activation des lymphocytes, Agranulocytes, Antigènes d'helminthe, Brugia malayi, Chitosane, Thiorédoxines, Vaccins.
- isolement et purification : Thiorédoxines.
- Animaux, Chitosane, Filariose lymphatique, Humains, Nanosphères, Spectroscopie infrarouge à transformée de Fourier, Vaccins.
English descriptors
- KwdEn :
- Animals, Antigens, Helminth (immunology), Brugia malayi (immunology), Chitosan (chemistry), Chitosan (immunology), Elephantiasis, Filarial (prevention & control), Humans, Leukocytes, Mononuclear (immunology), Lymphocyte Activation (immunology), Nanospheres (chemistry), Nanospheres (ultrastructure), Spectroscopy, Fourier Transform Infrared, Thioredoxins (administration & dosage), Thioredoxins (immunology), Thioredoxins (isolation & purification), Vaccines (chemistry), Vaccines (immunology).
- MESH :
- chemical , administration & dosage : Thioredoxins.
- chemical , chemistry : Chitosan, Vaccines.
- chemical , immunology : Antigens, Helminth, Chitosan, Thioredoxins, Vaccines.
- chemistry : Nanospheres.
- immunology : Brugia malayi, Leukocytes, Mononuclear, Lymphocyte Activation.
- chemical , isolation & purification : Thioredoxins.
- prevention & control : Elephantiasis, Filarial.
- ultrastructure : Nanospheres.
- Animals, Humans, Spectroscopy, Fourier Transform Infrared.
Abstract
Lymphatic filariasis (LF), a morbid vector-borne parasitic infection affects millions in tropical areas. Complete eradication can only be achieved by the development of a potent vaccine. Among the various filarial antigens that have been characterized, antigens Brugia malayi thioredoxin (TRX) and abundant larval transcript (ALT) have produced recognizable level of protection in Jirds, thereby evidenced to be good vaccine candidates. In this study an attempt was made to enhance their immunoprophylactic activity by encapsulating them in natural polysaccharide chitosan forming nanospheres (CN). High encapsulation efficiency for TRX (93%) in CN (TCN) and ALT-2 (90%) in CN (ACN) was achieved. Morphological studies confirmed the spherical and uniform distribution of nanospheres to be 220 nm. The electrostatic interaction between chitosan and the antigens were confirmed using differential scanning calorimetry and FT-IR. The study revealed the immunostimulatory property of chitosan providing enhanced level of proliferation for encapsulated antigens in peripheral blood mononuclear cells from endemic normal personals, at low concentration (TCN mean stimulation index (SI)=4.23±0.15 and ACN (SI)=4.05±0.33) compared to stimulation obtained by antigens alone. Hence, our study demonstrated that natural macromolecule derived CN can be used as efficacious immunostimulatory vaccine carter for LF thereby diminishing pathological sequel.
DOI: 10.1016/j.ijbiomac.2014.11.014
PubMed: 25433130
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001182
Links to Exploration step
pubmed:25433130Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.</title>
<author><name sortKey="Malathi, Balasubramaniyan" sort="Malathi, Balasubramaniyan" uniqKey="Malathi B" first="Balasubramaniyan" last="Malathi">Balasubramaniyan Malathi</name>
<affiliation wicri:level="1"><nlm:affiliation>Anna University, Guindy, Chennai 600025, Tamil Nadu, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mona, Santhanam" sort="Mona, Santhanam" uniqKey="Mona S" first="Santhanam" last="Mona">Santhanam Mona</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Thiyagarajan, Devasena" sort="Thiyagarajan, Devasena" uniqKey="Thiyagarajan D" first="Devasena" last="Thiyagarajan">Devasena Thiyagarajan</name>
<affiliation wicri:level="1"><nlm:affiliation>Anna University, Guindy, Chennai 600025, Tamil Nadu, India. Electronic address: tdevasenabio@annauniv.edu.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu, India. Electronic address: kaliraj55@yahoo.co.in.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25433130</idno>
<idno type="pmid">25433130</idno>
<idno type="doi">10.1016/j.ijbiomac.2014.11.014</idno>
<idno type="wicri:Area/PubMed/Corpus">001182</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001182</idno>
<idno type="wicri:Area/PubMed/Curation">001182</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001182</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.</title>
<author><name sortKey="Malathi, Balasubramaniyan" sort="Malathi, Balasubramaniyan" uniqKey="Malathi B" first="Balasubramaniyan" last="Malathi">Balasubramaniyan Malathi</name>
<affiliation wicri:level="1"><nlm:affiliation>Anna University, Guindy, Chennai 600025, Tamil Nadu, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mona, Santhanam" sort="Mona, Santhanam" uniqKey="Mona S" first="Santhanam" last="Mona">Santhanam Mona</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Thiyagarajan, Devasena" sort="Thiyagarajan, Devasena" uniqKey="Thiyagarajan D" first="Devasena" last="Thiyagarajan">Devasena Thiyagarajan</name>
<affiliation wicri:level="1"><nlm:affiliation>Anna University, Guindy, Chennai 600025, Tamil Nadu, India. Electronic address: tdevasenabio@annauniv.edu.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu, India. Electronic address: kaliraj55@yahoo.co.in.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of biological macromolecules</title>
<idno type="eISSN">1879-0003</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antigens, Helminth (immunology)</term>
<term>Brugia malayi (immunology)</term>
<term>Chitosan (chemistry)</term>
<term>Chitosan (immunology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Humans</term>
<term>Leukocytes, Mononuclear (immunology)</term>
<term>Lymphocyte Activation (immunology)</term>
<term>Nanospheres (chemistry)</term>
<term>Nanospheres (ultrastructure)</term>
<term>Spectroscopy, Fourier Transform Infrared</term>
<term>Thioredoxins (administration & dosage)</term>
<term>Thioredoxins (immunology)</term>
<term>Thioredoxins (isolation & purification)</term>
<term>Vaccines (chemistry)</term>
<term>Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Activation des lymphocytes (immunologie)</term>
<term>Agranulocytes (immunologie)</term>
<term>Animaux</term>
<term>Antigènes d'helminthe (immunologie)</term>
<term>Brugia malayi (immunologie)</term>
<term>Chitosane ()</term>
<term>Chitosane (immunologie)</term>
<term>Filariose lymphatique ()</term>
<term>Humains</term>
<term>Nanosphères ()</term>
<term>Nanosphères (ultrastructure)</term>
<term>Spectroscopie infrarouge à transformée de Fourier</term>
<term>Thiorédoxines (administration et posologie)</term>
<term>Thiorédoxines (immunologie)</term>
<term>Thiorédoxines (isolement et purification)</term>
<term>Vaccins ()</term>
<term>Vaccins (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Thioredoxins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Chitosan</term>
<term>Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Helminth</term>
<term>Chitosan</term>
<term>Thioredoxins</term>
<term>Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Thiorédoxines</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Nanospheres</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Activation des lymphocytes</term>
<term>Agranulocytes</term>
<term>Antigènes d'helminthe</term>
<term>Brugia malayi</term>
<term>Chitosane</term>
<term>Thiorédoxines</term>
<term>Vaccins</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Brugia malayi</term>
<term>Leukocytes, Mononuclear</term>
<term>Lymphocyte Activation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Thioredoxins</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Thiorédoxines</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrastructure" xml:lang="en"><term>Nanospheres</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
<term>Spectroscopy, Fourier Transform Infrared</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Chitosane</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Nanosphères</term>
<term>Spectroscopie infrarouge à transformée de Fourier</term>
<term>Vaccins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF), a morbid vector-borne parasitic infection affects millions in tropical areas. Complete eradication can only be achieved by the development of a potent vaccine. Among the various filarial antigens that have been characterized, antigens Brugia malayi thioredoxin (TRX) and abundant larval transcript (ALT) have produced recognizable level of protection in Jirds, thereby evidenced to be good vaccine candidates. In this study an attempt was made to enhance their immunoprophylactic activity by encapsulating them in natural polysaccharide chitosan forming nanospheres (CN). High encapsulation efficiency for TRX (93%) in CN (TCN) and ALT-2 (90%) in CN (ACN) was achieved. Morphological studies confirmed the spherical and uniform distribution of nanospheres to be 220 nm. The electrostatic interaction between chitosan and the antigens were confirmed using differential scanning calorimetry and FT-IR. The study revealed the immunostimulatory property of chitosan providing enhanced level of proliferation for encapsulated antigens in peripheral blood mononuclear cells from endemic normal personals, at low concentration (TCN mean stimulation index (SI)=4.23±0.15 and ACN (SI)=4.05±0.33) compared to stimulation obtained by antigens alone. Hence, our study demonstrated that natural macromolecule derived CN can be used as efficacious immunostimulatory vaccine carter for LF thereby diminishing pathological sequel.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25433130</PMID>
<DateCreated><Year>2015</Year>
<Month>01</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>09</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0003</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>73</Volume>
<PubDate><Year>2015</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>International journal of biological macromolecules</Title>
<ISOAbbreviation>Int. J. Biol. Macromol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.</ArticleTitle>
<Pagination><MedlinePgn>131-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijbiomac.2014.11.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0141-8130(14)00762-4</ELocationID>
<Abstract><AbstractText>Lymphatic filariasis (LF), a morbid vector-borne parasitic infection affects millions in tropical areas. Complete eradication can only be achieved by the development of a potent vaccine. Among the various filarial antigens that have been characterized, antigens Brugia malayi thioredoxin (TRX) and abundant larval transcript (ALT) have produced recognizable level of protection in Jirds, thereby evidenced to be good vaccine candidates. In this study an attempt was made to enhance their immunoprophylactic activity by encapsulating them in natural polysaccharide chitosan forming nanospheres (CN). High encapsulation efficiency for TRX (93%) in CN (TCN) and ALT-2 (90%) in CN (ACN) was achieved. Morphological studies confirmed the spherical and uniform distribution of nanospheres to be 220 nm. The electrostatic interaction between chitosan and the antigens were confirmed using differential scanning calorimetry and FT-IR. The study revealed the immunostimulatory property of chitosan providing enhanced level of proliferation for encapsulated antigens in peripheral blood mononuclear cells from endemic normal personals, at low concentration (TCN mean stimulation index (SI)=4.23±0.15 and ACN (SI)=4.05±0.33) compared to stimulation obtained by antigens alone. Hence, our study demonstrated that natural macromolecule derived CN can be used as efficacious immunostimulatory vaccine carter for LF thereby diminishing pathological sequel.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malathi</LastName>
<ForeName>Balasubramaniyan</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Anna University, Guindy, Chennai 600025, Tamil Nadu, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mona</LastName>
<ForeName>Santhanam</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Thiyagarajan</LastName>
<ForeName>Devasena</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Anna University, Guindy, Chennai 600025, Tamil Nadu, India. Electronic address: tdevasenabio@annauniv.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kaliraj</LastName>
<ForeName>Perumal</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Centre for Biotechnology, Anna University, Guindy, Chennai 600025, Tamil Nadu, India. Electronic address: kaliraj55@yahoo.co.in.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Int J Biol Macromol</MedlineTA>
<NlmUniqueID>7909578</NlmUniqueID>
<ISSNLinking>0141-8130</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>52500-60-4</RegistryNumber>
<NameOfSubstance UI="D013879">Thioredoxins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9012-76-4</RegistryNumber>
<NameOfSubstance UI="D048271">Chitosan</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017178" MajorTopicYN="N">Brugia malayi</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D048271" MajorTopicYN="N">Chitosan</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054118" MajorTopicYN="N">Nanospheres</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017550" MajorTopicYN="N">Spectroscopy, Fourier Transform Infrared</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013879" MajorTopicYN="N">Thioredoxins</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abundant larval transcript-2</Keyword>
<Keyword MajorTopicYN="N">Chitosan nanospheres</Keyword>
<Keyword MajorTopicYN="N">Lymphatic filariasis</Keyword>
<Keyword MajorTopicYN="N">PBMC</Keyword>
<Keyword MajorTopicYN="N">Thioredoxin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25433130</ArticleId>
<ArticleId IdType="pii">S0141-8130(14)00762-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijbiomac.2014.11.014</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001182 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001182 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25433130 |texte= Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25433130" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |